tykhr
sign in
free sign up
Navidea Biopharmaceuticals Inc
Biotechnology
Healthcare
NAVB
29.12M shares
NYSE MKT US
traded
22 Nov 2021
open
1.32
52 week high
2.90
high
1.32
52 week low
1.32
low
1.22
growth
-42.61%
previous Close
1.37
P/E ratio
-15
market cap
54.90M
div yield
0
usd
Jun 2021
qoq
revenue
261K
110.97 %
net incoming
-2.67M
9.87 %
eps
-0.09
18.18 %
eps surprise
0.00 %
net profit margin
-1024.36 %
1373.00 %
operating incoming
-2.67M
19.83 %
net change in cash
-393.22K
-108.13 %
cash on hand
7.11M
-5.24 %
cost of revenue
top